Skip to main content
SpringerLink
Log in

Surgical Management of Mesothelioma

  • Chapter
Tumors of the Chest

  • 811 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 179.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Peto J, Decarli A, La Vecchia C, Levi F, Tomei F, Negri E. The European mesothelioma epidemic. Br J Cancer 1999; 79:666.

    Article  PubMed  CAS  Google Scholar 

  2. Miller WJ, Gefter W, Miller WT. Asbestos-related chest diseases: plain radiographic findings. Semin Roentgenol 1992; 27:102.

    Article  PubMed  Google Scholar 

  3. Yilmaz U, Utkaner G, Yalniz E, Kvimcuoglu Z. Computed tomographic findings of environmental asbestos-related malignant pleural mesothelioma. Respirology 1998; 3:33.

    Article  PubMed  CAS  Google Scholar 

  4. Benard F, Sterman D, Smith RJ, Kaiser LR, Albelda SM, Alavi A. Metabolic imaging of malignant pleural mesothe lioma with fluorodeoxyglucose positron emission tomog raphy. Chest 1998; 114:713.

    PubMed  CAS  Google Scholar 

  5. Carretta A, Landoni C, Melloni G, Ceresoli G, Compierch-io A, Fazio F, et al. 18-FDG positron emission tomography in the study of malignant pleural diseases: a pilot study. Eur J Cardiothorac Surg 2000; 17:377.

    Article  PubMed  CAS  Google Scholar 

  6. Buchmann I, Guhlmann C, Eisner K, Gfrorer W, Schirr-meister H, Kotzerke, et al. F-18 FDG PET for the primary diagnosis of pleural processes. Nuklearmedizin 1999;38:319.

    PubMed  CAS  Google Scholar 

  7. Boutin C, Schlesser M, Frenay C, Astoul P. Malignant pleural mesothelioma. Eur Respir J 1998; 12:972.

    Article  PubMed  CAS  Google Scholar 

  8. Grossebner M, Arifi A, Goddard M, Ritchie A. Mesothe lioma: VATS biopsy and lung mobilization improves diag nosis and palliation. Eur J Cardiothorac Surg 1999;16:619.

    Article  PubMed  CAS  Google Scholar 

  9. Metintas M, Ozdemir N, Isikoy S, et al. CT-guided pleural needle biopsy in the diagnosis of malignant pleural meso thelioma. J Comput Assist Tomogr 1995; 19:370.

    Article  PubMed  CAS  Google Scholar 

  10. Paul S, Neragi-Miandoab S, Jaklitsch M. Preoperative as sessment and therapeutic options for patients with malig nant pleural mesothelioma. Thorac Surg Clin 2004;14:505.

    PubMed  Google Scholar 

  11. Mayinger B, Neidhardt S, Reh H, Martus P, Hahn E. Fluorescence induced with 5-aminolevulinic acid for the endoscopic detection and follow-up if esophageal lesions. Gastrointest Endsoc 2001; 54:572.

    Article  CAS  Google Scholar 

  12. Lam S, MacAulay C, le Rich J, Palcic B. Detection and lo calization of early lung cancer by fluorescence broncho-scopy. Cancer 2000; 89(suppl):2468.

    Article  PubMed  CAS  Google Scholar 

  13. Rodriguez E, Baas P, Friedberg J. Innovative therapies: photodynamic therapy. Thorac Surg Clin 14; 2004:557.

    PubMed  Google Scholar 

  14. Rusch V, Venkratraman E. Important prognostic factors in patients with malignant pleural mesothelioma, managed surgically. Ann Thorac Surg 1999; 68:1799.

    Article  PubMed  CAS  Google Scholar 

  15. Rusch V. The International Mesothelioma Interest Group. A proposed new international TNM staging system for malignant pleural mesothelioma. Chest 1995; 108:1122.

    PubMed  CAS  Google Scholar 

  16. Heelan R, Rusch V, Begg C, Panicek D, Caravelli J, Eisen C. Staging of malignant pleural mesothelioma: compari son of CT and MR imaging. Am J Roentgenol 1999;172:1039.

    CAS  Google Scholar 

  17. Rusch V, Venkratraman E. The importance of surgical staging in the treatment of malignant pleural mesothelio ma. J Thorac Cardiovasc Surg 1996; 111:815.

    Article  PubMed  CAS  Google Scholar 

  18. Flores R, Akhurst T, Gonen M, Larson S, Rusch V. Posi tron emission tomography defines metastatic disease but not locoregional disease in patients with malignant pleu ral mesothelioma. J Thorac Cardiovasc Surg 2003; 126:11.

    Article  PubMed  Google Scholar 

  19. Rice D, Vaporciyan A, Stevens C, et al. Extended surgical staging for potentially resectable mesothelioma. Presented at the Society for Thoracic Surgeons Annual Meeting, 2005.

    Google Scholar 

  20. Sugarbaker D, Mentzer S, DeCauld M, Lynch TJ Jr, Strauss G. Extrapleural pneumonectomy or pleurectomy in the 10. setting of multimodality approach to malignant mesothe-lioma. Chest 1993; 104:3775.

    Google Scholar 

  21. Sugarbaker D, Flores R, Jaklitsch M, et al. Resection mar gins, extrapleural nodal status and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients. J Thorac Cardiovasc Surg 1999; 117:54.

    Article  PubMed  CAS  Google Scholar 

  22. Curran D, Sahmoud T, Therasse P, et al. Prognostic fac tors in patients with pleural mesothelioma: the European Organization for Research and Treatment of Cancer ex perience. J Clin Oncol 1998; 16:145.

    PubMed  CAS  Google Scholar 

  23. Herndon J, Green M, Chahinian A, et al. Factors predic tive of survival among 337 patients with mesothelioma treated between 1984 and 1994 by the Cancer and Leuke mia Group B. Chest 1998; 113:723.

    PubMed  CAS  Google Scholar 

  24. Sugarbaker D, Jaklitsch M, Bueno R, et al. Prevention, early detection and management of complications after 328 consecutive extrapleural pneumonectomies. J Thorac Cardiovasc Surg 2004; 128:138.

    Article  PubMed  Google Scholar 

  25. Byrne J, Karavas A, Colson Y, et al. Cardiac decortication for occult constrictive cardiac physiology and left extra pleural pneumonectomy. Chest 2002; 122:2256.

    Article  PubMed  Google Scholar 

  26. Wittnich C, Trudel J, Zidulka A, Chiu R. Misleading “pul monary wedge pressure” after pneumonectomy: its impor tance in post-operative fluid therapy. Ann Thorac Surg 1986; 42:192.

    Article  PubMed  CAS  Google Scholar 

  27. Richardson J, Sabanathan S, Jones J, Shah RD, Cheema S, Mearns AJ. A prospective, randomized comparison of pre-operative and continuous balanced epidural or paraverte-bral bupivacaine on post-thoracotomy pain, pulmonary function and stress responses. Br J Anaesth 1999; 83:387.

    PubMed  CAS  Google Scholar 

  28. Hartigan P, Ng J. Anesthetic strategies for patients under going extrapleural pneumonectomy. Thorac Surg Clinic 2004; 14:575.

    Google Scholar 

  29. Amar D, Roistacher N, Rusch V, et al. Effects of diltiazem prophylaxis on the incidence and clinical outcome of at-rial arrhythmias after thoracic surgery. J Thorac Cardio vasc Surg 2000; 120:790.

    Article  CAS  Google Scholar 

  30. Mathru M, Blakeman B, Dries D, Kleinman B, Kumar P. Permeability pulmonary edema following lung resection. Chest 1990; 98:1216.

    PubMed  CAS  Google Scholar 

  31. Shapira O, Shahian D. Postpneumonectomy pulmonary edema. Ann Thorac Surg 1993; 56:190.

    Article  PubMed  CAS  Google Scholar 

  32. Alvarez J, Panda R, Newman M, Slinger P, Deslauriers J, Ferguson M. Postpneumonectomy pulmonary edema. J Cardiothorac Vase Anesth 2003; 17:388.

    Article  Google Scholar 

  33. Suen H, Hendrix H, Patterson G. Physiologic conse quences of pneumonectomy: consequences on the esopha-geal function. Chest Surg Clin N Am 1999; 9:475.

    PubMed  CAS  Google Scholar 

  34. Hilaris B, Nori D, Kwong E, et al. Pleurectomy and intra-operative brachytherapy and postoperative radiation in the treatment of malignant pleural mesothelioma. Int J Radiat Oncol Biol Phys 1984; 10:325.

    PubMed  CAS  Google Scholar 

  35. Soysal O, Karaoglanoglu N, Demiracan S, et al. Pleurec-tomy/decortication for palliation in malignant pleural mesothelioma: results of surgery. Eur J Cardiothorac Surg 1997; 11:210.

    Article  PubMed  CAS  Google Scholar 

  36. Van Ruth S, Baas P, Zoetmulder F. Surgical treatment of malignant pleural mesothelioma: a review. Chest 2003;123:551.

    Article  PubMed  Google Scholar 

  37. Baldini E, Recht A, Strauss G, et al. Patterns of failure after trimodality therapy for malignant pleural mesothe lioma. Ann Thorac Surg 1997; 63:334.

    Article  PubMed  CAS  Google Scholar 

  38. Mamon H, Yeap B, Janne P, et al. High risk of brain me-tastases in surgically staged IIIA non-small-cell lung can cer patients treated with surgery, chemotherapy, and ra diation. J Clin Oncol 2005; 23:1530.

    Article  PubMed  Google Scholar 

  39. Young S, Woodburn K, Wright M, et al. Lutetium texa-phyrin: a near-infrared, water soluble photosensitizer. Photochem Photobiol 1996; 63:892.

    PubMed  CAS  Google Scholar 

  40. Luketich JD, Westkaemper J, Sommers KE, et al. Broncho-esophagopleural fistula after photodynamic therapy for malignant mesothelioma. Ann Thorac Surg 1996; 62:283.

    Article  PubMed  CAS  Google Scholar 

  41. Litle VR, Luketich JD, Christie NA, et al. Photodynamic therapy as palliation for esophageal cancer: experience in 215 patients. Ann Thorac Surg 2003; 76:1687.

    Article  PubMed  Google Scholar 

  42. Freitag L, Ernst A, Thomas M, Prenzel R, Wahlers B, Ma-cha H. Sequential photodynamic therapy (PDT) and high dose brachytherapy for endobronchial tumour control in patients with limited bronchogenic carcinoma. Thorax 2004; 59:790.

    Article  PubMed  CAS  Google Scholar 

  43. Murrer H, Mariginissen H, Star W. Ex vivo light dosime-try and Monte Carlo simulations for endobronchial photo dynamic therapy. Phys Med Biol 1995; 40:1807.

    Article  PubMed  CAS  Google Scholar 

  44. Pass H, Temecj B, Kranda K, et al. Phase III randomized trial of surgery with or without intraoperative photody namic therapy, and postoperative immunochemotherapy for malignant pleural mesothelioma. Ann Surg Oncol 1997; 4:628.

    Article  PubMed  CAS  Google Scholar 

  45. Alberts D, Liu P, Hannigan E, et al. Intraperitoneal cispla-tin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer. N Engl J Med 1996; 335:1950.

    Article  PubMed  CAS  Google Scholar 

  46. Sugarbaker P. Treatment of peritoneal carcinomatosis from colon or appendiceal cancer with induction intra peritoneal chemotherapy. Cancer Treat Res 1996; 82:317.

    PubMed  CAS  Google Scholar 

  47. Tomek S, Mangold C. Chemotherapy for malignant pleu ral mesothelioma: past results and recent developments. Lung Cancer 2004; 455:S103.

    Article  Google Scholar 

  48. Howell S, Pfeifle C, Wung W, Olshen R. Intraperitoneal cis-diamminedichloroplatinum with systemic thiosulfate protection. Cancer Res 1983; 43:1426.

    PubMed  CAS  Google Scholar 

  49. Stehlin JS. Hyperthermic perfusion for melanoma of the extremities: experience with 165 patients, 1967 to 1979. Ann N Y Acad Sci 1980; 335:352.

    PubMed  Google Scholar 

  50. Giovonella B, Lohman W, Heidelberger C. Effects of ele vated temperatures and drugs on the viability of L1210 leukemia cells. Cancer Res 1970; 30:1623.

    Google Scholar 

  51. Howell S, Taetle R. Effect of sodium thiosulfate on cisdi-chlorodiammineplatinum (II) toxicity and antitumor ac tivity in L1210 leukemia. Cancer Treat Rep 1980; 64:611.

    PubMed  CAS  Google Scholar 

  52. Rusch V, Slatz L, Venkratraman E, et al. A phase II trial of pleurectomy/decortication followed by intrapleural and systemic chemotherapy for malignant pleural mesothelio ma. J Clin Oncol 1994; 12:1156.

    PubMed  CAS  Google Scholar 

  53. Chang M, Sugarbaker D. Innovative therapies: intraopera tive intracavitary chemotherapy. Thorac Surg Clin 2004;14:549.

    PubMed  Google Scholar 

  54. Kukreja J, Jaklitsch M, Wiener D, et al. Malignant pleural mesothelioma: overview of the North American and Eu ropean experience. Thorac Surg Clin 2004; 14:435.

    Article  PubMed  Google Scholar 

  55. Treasure T, Sedrakyan A. Pleural mesothelioma: little evi dence, still time to do trials. Lancet 2004; 364:1183.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Thoracic and Foregut Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA, USA

    Michael S. Kent, Sebastien Gilbert & James D. Luketich

Authors
  1. Michael S. Kent
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sebastien Gilbert
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. James D. Luketich
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Sotiria General Hospital, Athens Medical School, Athens, Greece

    Konstantinos N. Syrigos MD, PhD

  2. Royal Marsden NHS Trust Hospitals, London, UK

    Christopher M. Nutting MB BA, MD, FRCR

  3. Evangelismos General Hospital, Athens Medical School, Athens, Greece

    Charis Roussos MD, MSc, PhD, MRS, FRCP(C)

  4. Faculty of Medicine, McGill University, Montreal, Canada

    Charis Roussos MD, MSc, PhD, MRS, FRCP(C)

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer Berlin Heidelberg

About this chapter

Cite this chapter

Kent, M.S., Gilbert, S., Luketich, J.D. (2006). Surgical Management of Mesothelioma. In: Syrigos, K.N., Nutting, C.M., Roussos, C. (eds) Tumors of the Chest. Springer, Berlin, Heidelberg . https://doi.org/10.1007/3-540-31040-1_43

Download citation

  • DOI: https://doi.org/10.1007/3-540-31040-1_43

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-31039-6

  • Online ISBN: 978-3-540-31040-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation